Valuation: Novo Integrated Sciences, Inc.

Market Cap 19.73K 16.91K 15.84K 14.47K 27.31K 1.88M 27.58K 187K 72.74K 949K 74.08K 72.47K 3.14M P/E 2023
-1.08x
P/E 2024 -0.35x
Enterprise Value 5.16M 4.42M 4.14M 3.78M 7.14M 491M 7.21M 48.83M 19.01M 248M 19.36M 18.94M 821M EV / Sales 2023
2.07x
EV / Sales 2024 0.84x
Free-Float
93.41%
Yield 2023 *
-
Yield 2024 -
1 day-84.50%
1 week+416.67%
Current month-16.22%
1 month-20.51%
3 months-11.43%
Current year+14.81%
1 week 0
Extreme 0.0006
0
1 month 0
Extreme 0.0006
0
Current year 0
Extreme 0.0005
0.03
1 year 0
Extreme 0.0001
0.06
3 years 0
Extreme 0.0001
5.38
5 years 0
Extreme 0.0001
33.2
10 years 0
Extreme 0.0001
299
Manager TitleAgeSince
Director of Finance/CFO 40 2023-07-06
Chief Executive Officer 67 2017-05-08
Director TitleAgeSince
Director/Board Member 67 2014-08-12
Chairman 58 2018-10-17
Director/Board Member 52 2021-01-25
Date Insider Type Main position Quantity % Market Cap.
5/31/23 Other

Chief Operating Officer

2,000,000 1.3864%
8/9/22 Free

Director

39,480 0.1273%
4/19/22 Buy

Director

10,000 0.0348%
Change 5-day change 1-year change 3-year change Capi.($)
-84.50%+416.67%+244.44%-99.82% 11.84K
-1.29%-2.12%+30.46%+38.00% 119B
-0.11%+4.14%+6.45%+56.89% 92.83B
+0.02%-1.89%-3.12%+56.25% 30.13B
+0.26%+3.50%+36.86%+84.69% 26.99B
-2.41%+0.62%+50.85%+266.27% 21.89B
+1.13%+1.86%-1.67%-5.61% 22.44B
+4.49%+9.94%-3.94%+23.49% 15.27B
+0.15%-0.88%-7.52%-8.94% 12.48B
+0.74%-0.06%+29.47%+76.72% 11.34B
Average -8.01%+1.53%+38.23%+48.79% 35.22B
Weighted average by Cap. +0.22%+1.05%+18.10%+58.48%

Financials

2023 2024
Net sales 12.57M 10.77M 10.09M 9.22M 17.4M 1.2B 17.57M 119M 46.35M 605M 47.21M 46.18M 2B 13.29M 11.39M 10.67M 9.75M 18.4M 1.27B 18.58M 126M 49.02M 639M 49.92M 48.83M 2.12B
Net income -13.21M -11.32M -10.61M -9.69M -18.29M -1.26B -18.47M -125M -48.72M -636M -49.62M -48.54M -2.1B -16.17M -13.85M -12.98M -11.86M -22.38M -1.54B -22.6M -153M -59.61M -778M -60.7M -59.38M -2.58B
Net Debt 4.06M 3.48M 3.26M 2.97M 5.61M 387M 5.67M 38.41M 14.95M 195M 15.23M 14.9M 646M 5.14M 4.4M 4.12M 3.77M 7.11M 490M 7.18M 48.64M 18.94M 247M 19.28M 18.86M 818M
Logo Novo Integrated Sciences, Inc.
Novo Integrated Sciences, Inc. owns Canadian and United States subsidiaries which provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutics, diagnostic solutions, personalized product offerings, and rehabilitative science. It operates through two reportable segments: healthcare services and product sales. Its businesses include healthcare, medical technology, manufacturing, research and diagnostics, and products and brands. Its specialized primary health care services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, and others. Its products include Terragenx and ProDip (dietary supplement pouches). Terragenx is a micro-dosing IoNovo Iodine product for all ages and lifestyles. Its medical technologies include telemedicine, and remote patient monitoring.
Employees
190
Date Price Change Volume
26-08-25 US$0.000600 -.--% 7,575
26-08-21 US$0.000600 -.--% 1,033
26-08-20 US$0.000600 -72.09% 1,200
26-08-19 US$0.002150 +258.33% 1,129
  1. Stock Market
  2. Stocks
  3. NVOS Stock